LogicBio Therapeutics

AstraZeneca pays 666% premium to buy genomic medicine biotech
Fierce Biotech
Mon, 10/3/22 - 10:26 am
AstraZeneca
M&A
Alexion
LogicBio Therapeutics
genomic medicine
Intellia, LogicBio fuel hope for in vivo gene editing with new animal data in rare diseases: report
Fierce Biotech
Mon, 10/25/21 - 11:53 pm
Intellia Therapeutics
LogicBio Therapeutics
gene editing
NTLA-2001
ATTR amyloidosis
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts
Xconomy
Mon, 02/10/20 - 11:25 pm
LogicBio Therapeutics
gene editing
clinical trials
methylmalonic acidemia
FDA